The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
Open accessAbstract
Intravitreal injection of biodegradable nanoparticles (NP) holds promise for gene therapy and drug delivery to the back of the eye. In some cases, including gene therapy, NP need to diffuse rapidly from the site of injection in order to reach targeted cell types in the back of the eye, whereas in other cases it may be preferred for the particles to remain at the injection site and slowly release drugs that may then diffuse to the site of action. We studied the movements of polystyrene (PS) nanoparticles of various sizes and surface chemistries in fresh bovine vitreous. PS NP as large as 510 nm rapidly penetrated the vitreous gel when coated with polyethylene glycol (PEG), whereas the movements of NP 1190 nm in diameter or larger were highly restricted regardless of surface chemistry owing to steric obstruction. PS NP coated with primary amine groups (–NH2) possessed positively charged surfaces at the pH of bovine vitreous (pH = 7.2), and were immobilized within the vitreous gel. In comparison, PS NP coated with –COOH (possessing negatively charged surfaces) in the size range of 100–200 nm and at particle concentrations below 0.0025% (w/v) readily diffused through the vitreous meshwork; at higher concentrations (~0.1% w/v), these nanoparticles aggregated within vitreous. Based on the mobility of different sized PS-PEG NP, we estimated the average mesh size of fresh bovine vitreous to be ~550 ± 50 nm. The bovine vitreous behaved as an impermeable elastic barrier to objects sized 1190 nm and larger, but as a highly permeable viscoelastic liquid to non-adhesive objects smaller than 510 nm in diameter. Guided by these studies, we next sought to examine the transport of drug- and DNA-loaded nanoparticles in bovine vitreous. Biodegradable NP with diameter of 227 nm, composed of a poly(lactic-co-glycolic acid) (PLGA)-based core coated with poly(vinyl alcohol) rapidly penetrated vitreous. Rod-shaped, highly-compacted CK30PEG10k/DNA with PEG coating (neutral surface charge; diameter ~60 nm) diffused rapidly within vitreous. These findings will help guide the development of nanoparticle-based therapeutics for the treatment of vision-threatening ocular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Cheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Micro- and macrorheology of mucus
Lai, S. K., Wang, Y.-Y., Wirtz, D., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.012 · Cited by 1,223
Self-citationRapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Self-citationSolute Diffusion within Hydrogels. Mechanisms and Models
Amsden, B. (1998) · Macromolecules · doi:10.1021/ma980765f · Cited by 942
Age-related macular degeneration
de Jong, P. T. V. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062326 · Cited by 787
Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649
Self-citationNanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses
Lai, S. K., Wang, Y.-Y., Hida, K., Cone, R., & Hanes, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911748107 · Cited by 384
Self-citationSuk, J. S., Lai, S. K., Wang, Y.-Y., Ensign, L. M., Zeitlin, P. L., Boyle, M. P., & Hanes, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.076 · Cited by 352
Self-citationDrug delivery to the posterior segment of the eye
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.12.004 · Cited by 335
Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
Ensign, L. M., Schneider, C., Suk, J. S., Cone, R., & Hanes, J. (2012) · Advanced Materials · doi:10.1002/adma.201201800 · Cited by 290
Self-citationReal-time multiple-particle tracking: applications to drug and gene delivery
Suh, J., Dawson, M., & Hanes, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.06.001 · Cited by 274
Self-citationDrug delivery to the retina: challenges and opportunities
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.45 · Cited by 249
Liposomes for intravitreal drug delivery: A state of the art
Bochot, A., & Fattal, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.019 · Cited by 227
Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release
Yoo, H. S., Oh, J. E., Lee, K. H., & Park, T. G. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908421434 · Cited by 225
Stewart, M. W., Rosenfeld, P. J., Penha, F. M., Wang, F., Yehoshua, Z., Bueno-Lopez, E., & Lopez, P. F. (2011) · Retina · doi:10.1097/iae.0b013e31822c290f · Cited by 225
Apgar, J., Tseng, Y., Fedorov, E., Herwig, M. B., Almo, S. C., & Wirtz, D. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76363-6 · Cited by 216
Koo, H., Moon, H., Han, H., Na, J. H., Huh, M. S., Park, J. H., Woo, S. J., Park, K. H., Chan Kwon, I., Kim, K., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.030 · Cited by 214
Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
Farjo, R., Skaggs, J., Quiambao, A. B., Cooper, M. J., & Naash, M. I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000038 · Cited by 208
Relating microstructure to rheology of a bundled and cross-linked F-actin network in vitro
Shin, J. H., Gardel, M. L., Mahadevan, L., Matsudaira, P., & Weitz, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308733101 · Cited by 198
Vitreous: A Barrier to Nonviral Ocular Gene Therapy
Peeters, L., Sanders, N. N., Braeckmans, K., Boussery, K., Van de Voorde, J., De Smedt, S. C., & Demeester, J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0165 · Cited by 189 · cited 8×
“However, this experiment may suffer from artifacts, since removing bovine vitreous from the eyecup and then mixing it with particles could partly disrupt the fragile vitreous structure and cause aggregation of collagen fibrils [19].”
BackgroundMethodResultInfluentialSuk, J. S., Lai, S. K., Boylan, N. J., Dawson, M. R., Boyle, M. P., & Hanes, J. (2011) · Nanomedicine · doi:10.2217/nnm.10.123 · Cited by 185
Self-citationAn Obstruction-Scaling Model for Diffusion in Homogeneous Hydrogels
Amsden, B. (1999) · Macromolecules · doi:10.1021/ma980922a · Cited by 180
Kim, H., Robinson, S. B., & Csaky, K. G. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9745-6 · Cited by 174 · cited 1×
“Anionic human serum albumin (HSA) NP (~ 100 nm) were shown to effectively enter the retina after intravitreal injection, whereas positively charged HSA NP were unable to do so [50].”
BackgroundMarano, R. J., Toth, I., Wimmer, N., Brankov, M., & Rakoczy, P. E. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302579 · Cited by 164
Altering Mucus Rheology to “Solidify” Human Mucus at the Nanoscale
Lai, S. K., Wang, Y.-Y., Cone, R. A., Wirtz, D., & Hanes, J. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004294 · Cited by 155
Self-citationDrug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus
Lai, S. K., Suk, J. S., Pace, A., Wang, Y.-Y., Yang, M., Mert, O., Chen, J., Kim, J., & Hanes, J. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.008 · Cited by 149
Self-citationVitreous Is a Barrier in Nonviral Gene Transfer by Cationic Lipids and Polymers
Pitkänen, L., Ruponen, M., Nieminen, J., & Urtti, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1023238530504 · Cited by 134
Cai, X., Conley, S. M., Nash, Z. A., Fliesler, S. J., Cooper, M. J., & Naash, M. I. (2009) · The FASEB Journal · doi:10.1096/fj.09-139147 · Cited by 123
The biochemical structure of mammalian vitreous
Bishop, P. (1996) · Eye · doi:10.1038/eye.1996.159 · Cited by 120
Cai, X., Nash, Z., Conley, S. M., Fliesler, S. J., Cooper, M. J., & Naash, M. I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005290 · Cited by 109
Nanoparticles for retinal gene therapy
Conley, S. M., & Naash, M. I. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.004 · Cited by 106
Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Folk, J. C., & Stone, E. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmct1000495 · Cited by 99
Boylan, N. J., Suk, J. S., Lai, S. K., Jelinek, R., Boyle, M., Cooper, M. J., & Hanes, J. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.031 · Cited by 90
Self-citationBos, K. J., Holmes, D. F., Meadows, R. S., Kadler, K. E., McLeod, D., & Bishop, P. N. (2001) · Micron · doi:10.1016/s0968-4328(00)00035-4 · Cited by 67
Treatment of diabetic retinopathy with anti‐VEGF drugs
Waisbourd, M., Goldstein, M., & Loewenstein, A. (2010) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.02010.x · Cited by 66
Sanders, N. N., Peeters, L., Lentacker, I., Demeester, J., & Smedt, S. C. D. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.004 · Cited by 63
Brewton, R. G., & Mayne, R. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90376-j · Cited by 62
Reduction of fibronectin expression by intravitreal administration of antisense oligonucleotides
Roy, S., Zhang, K., Roth, T., Vinogradov, S. A., Kao, R. S., & Kabanov, A. V. (1999) · Nature Biotechnology · doi:10.1038/8654 · Cited by 61
Xu, J., Wang, Y., Li, Y., Yang, X., Zhang, P., Hou, H., Shi, Y., & Song, C. (2007) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2007.0002 · Cited by 60
Self-citationShelke, N. B., Kadam, R. S., Tyagi, P., Rao, V. R., & Kompella, U. B. (2010) · Drug Delivery and Translational Research · doi:10.1007/s13346-010-0009-8 · Cited by 60
Boylan, N. J., Kim, A. J., Suk, J. S., Adstamongkonkul, P., Simons, B. W., Lai, S. K., Cooper, M. J., & Hanes, J. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.080 · Cited by 54
Self-citationNon-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles
Kim, A. J., Boylan, N. J., Suk, J. S., Lai, S. K., & Hanes, J. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.031 · Cited by 48
Self-citationDrug Product Development for the Back of the Eye
Kompella, U. B., & Edelhauser, H. F. (2011) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4419-9920-7 · Cited by 44
Update on nonsurgical therapy for diabetic macular edema
Witkin, A. J., & Brown, G. C. (2011) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3283459724 · Cited by 36
Internal Tension: A Novel Hypothesis Concerning the Mechanical Properties of the Vitreous Humor
Nickerson, C. S., Karageozian, H. L., Park, J., & Kornfield, J. A. (2005) · Macromolecular Symposia · doi:10.1002/masy.200550918 · Cited by 32
Microparticles as Drug Delivery Systems for the Back of the Eye
Herrero‐Vanrell, R. (2011) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4419-9920-7_10 · Cited by 10
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Self-citationPharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
A swarm of slippery micropropellers penetrates the vitreous body of the eye
Wu, Z., Troll, J., Jeong, H.-H., Wei, Q., Stang, M., Ziemssen, F., Wang, Z., Dong, M., Schnichels, S., Qiu, T., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat4388 · Cited by 567
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Leal, J., Smyth, H. D. C., & Ghosh, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.018 · Cited by 560
Jo, D. H., Kim, J. H., Lee, T. G., & Kim, J. H. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.04.015 · Cited by 433
Metadata
- Authors
- Xu, Q., Boylan, N. J., Suk, J. S., Wang, Y.-Y., Nance, E. A., Yang, J.-C., McDonnell, P. J., Cone, R. A., Duh, E. J., & Hanes, J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 167
- Issue
- 1
- Pages
- 76-84
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2079159055
- Cited by
- 326
- References
- 50
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.